Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (111-120 of 270) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancerAlan I So, Randy J Levitt, Bernhard Eigl, et al.
Human Pathology|September 26, 2006
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumorsLatif A Wafa, Jodie Palmer, Ladan Fazli, et al.
The Prostate|February 24, 2006
Loss of PTEN is associated with progression to androgen independenceJerod Bertram, James W Peacock, Ladan Fazli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
The mechanism of DAB2IP in chemoresistance of prostate cancer cellsKaijie Wu, Daxing Xie, Yonglong Zou, et al.
Neoplasia (New York, N.Y.)|December 19, 2015
Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell CarcinomaKyung Seok Han, Peter A Raven, Sebastian Frees, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumorsRobert Snoek, Helen Cheng, Katia Margiotti, et al.
Cancer Research|March 16, 2013
Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancerMasaki Shiota, Jennifer L Bishop, Ka Mun Nip, et al.
Ebiomedicine|April 17, 2017
c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene NetworksStefan J Barfeld, Alfonso Urbanucci, Harri M Itkonen, et al.
Plos One|February 25, 2017
Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapyMichael L Blute, Nathan Damaschke, Jennifer Wagner, et al.
Oncotarget|April 15, 2015
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancerStefan J Barfeld, Ladan Fazli, Margareta Persson, et al.
Pageof 27

Showing results (111-120 of 270) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancerAlan I So, Randy J Levitt, Bernhard Eigl, et al.
Human Pathology|September 26, 2006
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumorsLatif A Wafa, Jodie Palmer, Ladan Fazli, et al.
The Prostate|February 24, 2006
Loss of PTEN is associated with progression to androgen independenceJerod Bertram, James W Peacock, Ladan Fazli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
The mechanism of DAB2IP in chemoresistance of prostate cancer cellsKaijie Wu, Daxing Xie, Yonglong Zou, et al.
Neoplasia (New York, N.Y.)|December 19, 2015
Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell CarcinomaKyung Seok Han, Peter A Raven, Sebastian Frees, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumorsRobert Snoek, Helen Cheng, Katia Margiotti, et al.
Cancer Research|March 16, 2013
Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancerMasaki Shiota, Jennifer L Bishop, Ka Mun Nip, et al.
Ebiomedicine|April 17, 2017
c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene NetworksStefan J Barfeld, Alfonso Urbanucci, Harri M Itkonen, et al.
Plos One|February 25, 2017
Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapyMichael L Blute, Nathan Damaschke, Jennifer Wagner, et al.
Oncotarget|April 15, 2015
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancerStefan J Barfeld, Ladan Fazli, Margareta Persson, et al.
Pageof 27